Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only

Clinical efficacy and reduction effect on prostatic volume of chlormadinone acetate combined with tamsulosin hydrochloride in benign prostatic hyperplasia patients insufficiently treated with tamsulosin hydrochloride only

Alpha adrenergic blocker has become the first choice in the medical treatment of benign prostatic hyperplasia (BPH). The efficacy of alpha adrenergic blocker has been suggested to be related to the prostatic tissue components, and to be ineffective in treating the clinical symptoms caused by BPH in...

Ausführliche Beschreibung

Bibliographische Detailangaben
Veröffentlicht in:Hinyokika kiyo. Acta urologica Japonica. - 1962. - 44(1998), 8 vom: 25. Aug., Seite 565-73
1. Verfasser: Ueki, O (VerfasserIn)
Weitere Verfasser: Kawaguchi, K, Katsumi, T, Murayama, K, Kameda, K, Nishino, A, Sakai, A, Haginaka, T, Miyazaki, K, Asari, T, Egawa, M
Format: Aufsatz
Sprache:Japanese
Veröffentlicht: 1998
Zugriff auf das übergeordnete Werk:Hinyokika kiyo. Acta urologica Japonica
Schlagworte:Journal Article Adrenergic alpha-Antagonists Delayed-Action Preparations Progesterone Congeners Sulfonamides Chlormadinone Acetate 0SY050L61N Tamsulosin G3P28OML5I